Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
F 13.98 0.65% 0.09
CARA closed up 0.65 percent on Wednesday, June 23, 2021, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CARA trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Death Cross Bearish 0.65%
Down 3 Days in a Row Weakness 0.65%
Overbought Stochastic Strength -2.51%
New Downtrend Bearish -3.92%
Upper Bollinger Band Walk Strength -3.92%
Weak + Overbought Other -3.92%
Overbought Stochastic Strength -3.92%
Gapped Down Weakness -3.92%
Older End-of-Day Signals for CARA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 14 hours ago
Possible NR7 about 14 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Up 2% about 18 hours ago
Up 1% about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Clinical Trial Chronic Pain Amines Piperidines Mesoblast Acute And Chronic Pain

Is CARA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.6473
52 Week Low 11.8
Average Volume 1,008,357
200-Day Moving Average 16.85
50-Day Moving Average 16.50
20-Day Moving Average 13.83
10-Day Moving Average 14.23
Average True Range 0.57
ADX 25.38
+DI 19.90
-DI 26.56
Chandelier Exit (Long, 3 ATRs) 13.28
Chandelier Exit (Short, 3 ATRs) 14.68
Upper Bollinger Bands 14.80
Lower Bollinger Band 12.86
Percent B (%b) 0.58
BandWidth 14.05
MACD Line -0.31
MACD Signal Line -0.55
MACD Histogram 0.2387
Fundamentals Value
Market Cap 696.65 Million
Num Shares 49.8 Million
EPS -2.17
Price-to-Earnings (P/E) Ratio -6.45
Price-to-Sales 24.99
Price-to-Book 5.73
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.48
Resistance 3 (R3) 14.49 14.34 14.40
Resistance 2 (R2) 14.34 14.21 14.34 14.37
Resistance 1 (R1) 14.16 14.14 14.09 14.15 14.34
Pivot Point 14.01 14.01 13.97 14.00 14.01
Support 1 (S1) 13.83 13.88 13.75 13.81 13.62
Support 2 (S2) 13.68 13.80 13.67 13.59
Support 3 (S3) 13.49 13.68 13.56
Support 4 (S4) 13.48